Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Spectris Plc LSE:SXS London Ordinary Share GB0003308607 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  46.00 1.49% 3,130.00 3,131.00 3,133.00 3,158.00 3,085.00 3,158.00 157,454 16:35:17
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 1,336.2 -4.1 -14.6 - 3,636

Spectris Share Discussion Threads

Showing 351 to 374 of 450 messages
Chat Pages: 18  17  16  15  14  13  12  11  10  9  8  7  Older
DateSubjectAuthorDiscuss
19/4/2013
14:22
Spectris (LON:SXS) – IMS reports Q1 sales down 9% • Spectris results show lower Q1 sales due mainly through new Chinese capital discipline and US sequestration. • The business supplies measurement instrumentation equipment into Automotive, Defence, Oil &Gas, Electronics, Government R&D, Mining, Pulp & Paper • On a combination of stronger comparatives but slowing customer spend it saw Q1 sales down 9% - the impact was across the board sector wise. • Its regional sales are broadly spread across U.S., Asia and Europe. It saw Asia sales down 15%, North America down 10% and Europe down 6% • Lower sales in China on a change of government and slowing pace of growth, in the U.S. on sequestration are tempered with better expectations for Japan where new QE expected to encourage new growth. • Spectris is already seeing a pick up in orders for Q2, expects sales to bounce back 9% in that period and has a strong opportunity pipeline. We note though that it only has circa 8-10 weeks visibility. • Given it has broad end industry and geographic exposure, it is an interesting indicator of capital equipment spend trends. • Mining related sales for Spectris X-ray analysis systems are lower on caution in the sector on capital spend. • Mining should remain a good sector for Spectris as mines work towards better efficiency through the installation of new laboratories and analysis systems.
dasv
19/4/2013
11:19
I don't currently see anything likely to drive the price higher in the short term and will have to wait until July when we get another update and can judge whether Q1 was a one-off. Happy to hold in the meantime as I believe the Spectris management team have been sure footed in the past.
pearlfisher
19/4/2013
09:52
I too have Renishaw - similarly bruised - although I don't have much exposure in truth to either. (Should point out I sold SXS on open).
dasv
19/4/2013
09:10
There appears to have been a sector knock-on as a result of this mornings announcement with Renishaw down 6%. Their IMS is due on May 9 so it will be interesting to see if they have seen a similar decline in Q1 business and their outlook for the year. As an investor in both companies I am a little bruised this morning.
pearlfisher
19/4/2013
08:27
Ouch, I got that one wrong.
pearlfisher
19/4/2013
08:27
Disappointing - I wasn't expecting such a severe drop in revenue. The asian falls surprised me in particular. I sold at a loss but will continue to watch.
dasv
19/4/2013
08:09
TRADING UPDATE On a reported and constant currency organic basis, sales for the three months ended 31 March 2013 declined by 8% and 9% respectively, delivering a slower than expected start to the year. The decline is due to a combination of the strong comparative prior year period and weaker customer confidence leading to deferral of orders and shipment delays. This weakness was experienced across all of our major regions, all reporting segments and the majority of our end markets. Regionally, sales in Asia Pacific declined by 15% on a like-for-like basis, North America declined 10% and Europe declined 6% in the quarter compared with the first quarter of last year. At this stage we have no reason to believe that any deferred orders will be cancelled and our opportunity pipeline remains strong and supportive of revenue growth for the full year, albeit at a more moderate rate than previously anticipated. Therefore, we have taken actions to reduce our cost base for 2013 by approximately £10 million which underpins our full year profit. FINANCIAL POSITION Beyond the disposal of Fusion UV, there was no significant event or transaction during this period which resulted in a material impact on the financial position of the group. The company continues to maintain a healthy financial position. Net debt at 31 March 2013 was approximately £138 million, a reduction of around £116 million in the quarter reflecting the receipt of the gross proceeds from the sale of Fusion UV and continued strong operating cash flow. OUTLOOK Whilst we now expect top-line growth in 2013 to be slightly lower than previously anticipated, our strong opportunity pipeline and cost reduction initiatives leave us optimistic that we will deliver full year performance broadly in line with our expectations at the beginning of the year.
dasv
18/4/2013
16:06
IMS tomorrow.
broadwood
11/4/2013
10:32
pearl - well done. Share price running up ahead of IMS.
broadwood
09/4/2013
10:22
AGM and Interim Statement on Apr 19. Bought back in today at average of 2266 having sold around the 2400 mark some weeks ago. Will add a few more if we see 2200.
pearlfisher
25/3/2013
11:12
One of the stocks mentioned in a 'great British high tec companies' type article in the Sunday Times.
bluebelle
14/3/2013
13:57
Aye heading for 2500 again.
enami
14/3/2013
09:52
Compelling story with the amount of cash being thrown off. I'm with BlackRock - they are a superb indicator. We reduced our net debt by GBP102 million thanks to strong cash flow conversion, with 93% of our operating profit being converted into operating cash flow due to good working capital management. At the end of December 2012, our net debt stood at GBP254 million, just over 1.0x our EBITDA of GBP249 million. On 18 December 2012, we signed an agreement to sell Fusion UV to Heraeus Holding GmbH for a total consideration of $172 million. This transaction completed on 31 January 2013
broadwood
13/3/2013
07:21
Nice increase in TP. Jefferies International Spectris PLC 13/03/2013 Reiterates Buy Buy 0 2,270.00 2,675.00 2,380.00 405 2
broadwood
12/3/2013
16:10
Probably the best indicator of all - BlackRock holding now over 10%.
broadwood
12/3/2013
15:55
Boosted today, Blackrock buying, bullish engulfing candle so far and up off bottom of trend channel.
enami
08/3/2013
10:47
Eye of the storm? A step down following director sale 25 Feb. Directors have awarded themselves a bunch of options. Almost at bottom of uptrend channel.
enami
22/2/2013
10:00
Looks like another South Wester a blowin' up Cap'n.
broadwood
22/2/2013
09:24
Took a breather for a day. Normal service resumed.
broadwood
20/2/2013
09:37
I've hoisted the mainsail again Cap'n.
broadwood
20/2/2013
09:06
Productivity-enhancing instrumentation company Spectris posted an 11 per cent rise in annual sales for 2012, contributing to the same percentage rise in adjusted earnings per share. Sales for the 12 months climbed from £1,106.2m to £1,230.8m year-on-year, while adjusted profit before tax increased to £217.3m from £191.6m, resulting in adjusted earnings per share of 137.5p (2011: 124.1p). Actual pre-tax profit totalled £186.7m, compared to £166m the previous year. The dividend was increased by 16% from 33.6p to 39.0p per share. John O'Higgins, Chief Executive, said: "This strong result was achieved through the progress we made on all aspects of our strategy. We will continue to invest in new products and applications which enhance our customers' productivity, seek further geographic growth opportunities across the group, and improve the resilience of the business through organic and acquisition activities. "The board is confident that Spectris continues to be strategically well-positioned for 2013 and beyond." The group said it expects to see growth in its Life Sciences sector continue, but said its Mining sector looks set to continue to slow in the first half of 2013. "We also see potential in the emerging nano-materials sector, creating demand from academic research institutions, as well as in-house research and development laboratories in the pharmaceutical and advanced materials sectors," it said. Sales in Test & Measurement rose 3.0% on a like-for-like basis, while operating profit grew 0.7%, helped by strong demand from the electronics and telecoms markets and continued growth in automotive. In-line Instrumentation sales climbed 4.0%, and operating profit rose 0.5%, after it experienced good demand from Asia Pacific, Japan and China in particular
broadwood
20/2/2013
08:51
Healthy cash position too.
bluebelle
20/2/2013
08:27
Oriel Securities Spectris PLC 20/02/2013 Reiterates Buy Buy 0 2,700.00 2,700.00 2,425.00 0 2
broadwood
20/2/2013
08:21
Instrumentation and controls company Spectris booked double-digit percentage rises in full-year sales and pretax profit, driven by both organic and acquisitive growth. The company posted a pretax profit of £186.7 million, up 12% year on year, while sales rose to £1.23 billion, up 13%. Chief executive John O'Higgins said the strong result was achieved through the progress on all aspects of Spectris' strategy. "We will continue to invest in new products and applications which enhance our customers' productivity, seek further geographic growth opportunities across the group, and improve the resilience of the business through organic and acquisition activities," he said. "The board is confident that Spectris continues to be strategically well-positioned for 2013 and beyond," O'Higgins added.
broadwood
Chat Pages: 18  17  16  15  14  13  12  11  10  9  8  7  Older
ADVFN Advertorial
Your Recent History
LSE
SXS
Spectris
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210514 20:16:15